PMID- 35794249 OWN - NLM STAT- MEDLINE DCOM- 20220809 LR - 20221104 IS - 1476-5594 (Electronic) IS - 0950-9232 (Print) IS - 0950-9232 (Linking) VI - 41 IP - 32 DP - 2022 Aug TI - FOXM1 regulates glycolysis and energy production in multiple myeloma. PG - 3899-3911 LID - 10.1038/s41388-022-02398-4 [doi] AB - The transcription factor, forkhead box M1 (FOXM1), has been implicated in the natural history and outcome of newly diagnosed high-risk myeloma (HRMM) and relapsed/refractory myeloma (RRMM), but the mechanism with which FOXM1 promotes the growth of neoplastic plasma cells is poorly understood. Here we show that FOXM1 is a positive regulator of myeloma metabolism that greatly impacts the bioenergetic pathways of glycolysis and oxidative phosphorylation (OxPhos). Using FOXM1-deficient myeloma cells as principal experimental model system, we find that FOXM1 increases glucose uptake, lactate output, and oxygen consumption in myeloma. We demonstrate that the novel 1,1-diarylethylene small-compound FOXM1 inhibitor, NB73, suppresses myeloma in cell culture and human-in-mouse xenografts using a mechanism that includes enhanced proteasomal FOXM1 degradation. Consistent with the FOXM1-stabilizing chaperone function of heat shock protein 90 (HSP90), the HSP90 inhibitor, geldanamycin, collaborates with NB73 in slowing down myeloma. These findings define FOXM1 as a key driver of myeloma metabolism and underscore the feasibility of targeting FOXM1 for new approaches to myeloma therapy and prevention. CI - (c) 2022. The Author(s). FAU - Cheng, Yan AU - Cheng Y AUID- ORCID: 0000-0001-7877-9622 AD - Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. FAU - Sun, Fumou AU - Sun F AUID- ORCID: 0000-0003-2034-3492 AD - Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. FAU - Thornton, Krista AU - Thornton K AD - Department of Pathology Master of Science Graduate Program, University of Iowa, Iowa City, IA, USA. FAU - Jing, Xuefang AU - Jing X AUID- ORCID: 0000-0002-8670-4505 AD - Department of Pathology, University of Iowa, Iowa City, IA, USA. FAU - Dong, Jing AU - Dong J AUID- ORCID: 0000-0001-9856-5963 AD - Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. FAU - Yun, Grant AU - Yun G AD - Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. FAU - Pisano, Michael AU - Pisano M AD - Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. AD - Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, USA. FAU - Zhan, Fenghuang AU - Zhan F AUID- ORCID: 0000-0001-5417-2973 AD - Myeloma Center, Division of Hematology and Oncology, Department of Medicine, and Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. FAU - Kim, Sung Hoon AU - Kim SH AD - Departments of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA. FAU - Katzenellenbogen, John A AU - Katzenellenbogen JA AUID- ORCID: 0000-0003-0914-0010 AD - Departments of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA. FAU - Katzenellenbogen, Benita S AU - Katzenellenbogen BS AUID- ORCID: 0000-0002-8847-2752 AD - Molecular and Integrative Physiology, and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, USA. FAU - Hari, Parameswaran AU - Hari P AD - Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. AD - Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA. FAU - Janz, Siegfried AU - Janz S AUID- ORCID: 0000-0002-2229-5511 AD - Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. sjanz@mcw.edu. AD - Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA. sjanz@mcw.edu. LA - eng GR - R42 CA180190/CA/NCI NIH HHS/United States GR - R01 CA151354/CA/NCI NIH HHS/United States GR - P30 CA086862/CA/NCI NIH HHS/United States GR - R41 CA180190/CA/NCI NIH HHS/United States GR - R01 CA236814/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20220706 PL - England TA - Oncogene JT - Oncogene JID - 8711562 RN - 0 (FOXM1 protein, human) RN - 0 (Forkhead Box Protein M1) RN - 0 (Forkhead Transcription Factors) RN - 0 (Transcription Factors) SB - IM MH - Animals MH - Cell Line, Tumor MH - Cell Proliferation MH - Forkhead Box Protein M1/genetics/metabolism MH - Forkhead Transcription Factors/genetics/metabolism MH - Gene Expression Regulation MH - Gene Expression Regulation, Neoplastic MH - Glycolysis MH - Humans MH - Mice MH - *Multiple Myeloma/genetics/metabolism MH - Transcription Factors/metabolism PMC - PMC9355869 COIS- The authors declare no competing interests. EDAT- 2022/07/07 06:00 MHDA- 2022/08/10 06:00 PMCR- 2022/07/06 CRDT- 2022/07/06 23:28 PHST- 2022/01/06 00:00 [received] PHST- 2022/06/21 00:00 [accepted] PHST- 2022/06/16 00:00 [revised] PHST- 2022/07/07 06:00 [pubmed] PHST- 2022/08/10 06:00 [medline] PHST- 2022/07/06 23:28 [entrez] PHST- 2022/07/06 00:00 [pmc-release] AID - 10.1038/s41388-022-02398-4 [pii] AID - 2398 [pii] AID - 10.1038/s41388-022-02398-4 [doi] PST - ppublish SO - Oncogene. 2022 Aug;41(32):3899-3911. doi: 10.1038/s41388-022-02398-4. Epub 2022 Jul 6.